BioStock: Erika Samuelsson new CDO at Cyxone

At the beginning of the autumn, First North-listed Cyxone announced the recruitment of Erika Samuelsson as the new Chief Development Officer with responsibility for clinical and non-clinical activities with Cyxone's drug candidates. BioStock had the opportunity to ask Erika a few questions about her background, new role and goals.

Read the interview with Cyxone's CDO Erika Samuelsson at biostock.se:

https://www.biostock.se/en/2022/09/erika-samuelsson-new-cdo-at-cyxone/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/